Signal transduction and desensitization of the glucagon-like peptide-1 receptor.
Thorens
B
B
Institute of Pharmacology and Toxicology, University of Lausanne, Switzerland.
Widmann
C
C
D000818:Animals; D000242:Cyclic AMP / Q000096:biosynthesis; D017353:Gene Deletion; D005934:Glucagon / Q000378:metabolism / Q000494:pharmacology*; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007340:Insulinoma; D009154:Mutation / Q000502:physiology; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology*; D010766:Phosphorylation; D011498:Protein Precursors / Q000378:metabolism / Q000494:pharmacology*; D018027:Receptors, Glucagon / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D012680:Sensitivity and Specificity; D015398:Signal Transduction / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000737:chemistry / Q000502:physiology
D010446:Peptide Fragments; D011498:Protein Precursors; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D000242:Cyclic AMP